JP2006527233A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527233A5
JP2006527233A5 JP2006515904A JP2006515904A JP2006527233A5 JP 2006527233 A5 JP2006527233 A5 JP 2006527233A5 JP 2006515904 A JP2006515904 A JP 2006515904A JP 2006515904 A JP2006515904 A JP 2006515904A JP 2006527233 A5 JP2006527233 A5 JP 2006527233A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
several
benzoylamino
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006515904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006527233A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/006330 external-priority patent/WO2004110983A2/en
Publication of JP2006527233A publication Critical patent/JP2006527233A/ja
Publication of JP2006527233A5 publication Critical patent/JP2006527233A5/ja
Pending legal-status Critical Current

Links

JP2006515904A 2003-06-13 2004-06-11 PPARγ調節物質としての新規ベンズアミド Pending JP2006527233A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301461 2003-06-13
PCT/EP2004/006330 WO2004110983A2 (en) 2003-06-13 2004-06-11 New benzamides as pparϒ modulators

Publications (2)

Publication Number Publication Date
JP2006527233A JP2006527233A (ja) 2006-11-30
JP2006527233A5 true JP2006527233A5 (cg-RX-API-DMAC10.html) 2007-08-16

Family

ID=33547865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006515904A Pending JP2006527233A (ja) 2003-06-13 2004-06-11 PPARγ調節物質としての新規ベンズアミド

Country Status (20)

Country Link
US (1) US20060160894A1 (cg-RX-API-DMAC10.html)
EP (1) EP1644321B1 (cg-RX-API-DMAC10.html)
JP (1) JP2006527233A (cg-RX-API-DMAC10.html)
KR (1) KR20060061300A (cg-RX-API-DMAC10.html)
CN (1) CN1835914A (cg-RX-API-DMAC10.html)
AT (1) ATE497945T1 (cg-RX-API-DMAC10.html)
AU (1) AU2004247389C1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0411412A (cg-RX-API-DMAC10.html)
CA (1) CA2528231A1 (cg-RX-API-DMAC10.html)
CR (1) CR8173A (cg-RX-API-DMAC10.html)
DE (1) DE602004031339D1 (cg-RX-API-DMAC10.html)
EA (1) EA008798B1 (cg-RX-API-DMAC10.html)
EC (1) ECSP056260A (cg-RX-API-DMAC10.html)
GE (1) GEP20084477B (cg-RX-API-DMAC10.html)
IL (1) IL172385A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA05013653A (cg-RX-API-DMAC10.html)
NZ (1) NZ544468A (cg-RX-API-DMAC10.html)
UA (1) UA84429C2 (cg-RX-API-DMAC10.html)
WO (1) WO2004110983A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200600059B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122580B2 (en) 2002-08-09 2006-10-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
WO2005014532A1 (en) 2003-08-08 2005-02-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
DE102005004885B4 (de) * 2005-02-03 2010-09-30 Bruker Daltonik Gmbh Transport von Ionen ins Vakuum
CN101267813A (zh) * 2005-07-19 2008-09-17 第一三共株式会社 取代丙酰胺衍生物和含有其的药物组合物
CN101233105B (zh) * 2005-07-20 2010-11-24 染井正德 色氨酸衍生物及其用途
WO2008094860A2 (en) 2007-01-30 2008-08-07 Allergan, Inc. Treating ocular diseases using peroxisome proliferator-activated receptor delta antagonists
AU2008338963A1 (en) * 2007-12-13 2009-06-25 Sri International PPAR-delta ligands and methods of their use
US8372885B2 (en) * 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
CN103201279A (zh) 2010-11-05 2013-07-10 赛诺米克斯公司 作为trpm8的调节剂有用的化合物
JP6007417B2 (ja) * 2011-05-31 2016-10-12 レセプトス エルエルシー 新規glp−1受容体安定剤および調節剤
JP6573604B2 (ja) 2013-06-11 2019-09-11 セルジーン インターナショナル ツー エスエーアールエル 新規なglp−1レセプターモジュレーター
CA2969944A1 (en) 2014-12-10 2016-06-16 Celgene International Ii Sarl Glp-1 receptor modulators
BR112018006471B1 (pt) 2015-10-01 2024-02-27 Senomyx, Inc Composto, composição, método de modular o membro de melastina do canal potencial do receptor transitório 8 (trpm8), método de modular a sensação de resfrescância de uma composição e método de induzir uma sensação de refrescância em um ser humano ou animal
CN107176914B (zh) * 2016-03-09 2022-06-28 浙江旭晨医药科技有限公司 新型gvs系列化合物及其用途
WO2018011230A1 (en) * 2016-07-13 2018-01-18 Universite D'aix-Marseille Peroxisome proliferator-activated receptor gamma agonists, method of preparation and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502764A1 (en) * 1995-08-22 1997-03-06 Japan Tobacco Inc. Amide compounds
JPH09124571A (ja) * 1995-11-01 1997-05-13 Japan Tobacco Inc アミド化合物及びその用途
CA2244831A1 (en) * 1996-02-02 1997-08-07 John T. Olson Method of treating diabetes and related disease states
AU3742100A (en) * 1999-03-16 2000-10-04 Glaxo Group Limited Nuclear receptor arylating compounds
TWI302149B (en) * 1999-09-22 2008-10-21 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
US7122580B2 (en) * 2002-08-09 2006-10-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation

Similar Documents

Publication Publication Date Title
JP4931893B2 (ja) Ppar活性化化合物及びこれを含有する医薬組成物
JP4803946B2 (ja) 置換フェニルプロピオン酸誘導体
US7427685B2 (en) Therapeutic substituted cyclopentanes
RU2293721C2 (ru) Сложноэфирные соединения и их применение в медицине
JP5988379B2 (ja) スフィンゴシン−1−リン酸受容体変調因子および不斉合成方法
HUP0203532A2 (hu) HPPAR-alfa aktivátor szubsztituált oxazol- és tiazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
JP2006516254A (ja) Pparモジュレータとしての縮合ヘテロ環誘導体
WO2009083526A1 (en) Novel compounds
JP2007515484A (ja) トリアゾール、オキサジアゾール、及びチアジアゾール誘導体のppar修飾物質
HUP0002053A2 (hu) Tiazol-benzol-szulfonamidok mint diabétesz és elhízás kezelésére szolgáló béta3-agonisták
JP2006520755A (ja) Pparモジュレータとしてのスルホンアミド誘導体
US20100216750A1 (en) Tricyclic inhibitors of fatty acid amide hydrolase
CZ2001490A3 (cs) Oxazolové a thiazolové deriváty
HUP0201858A2 (en) Thiazole and oxazole derivatives and their pharmaceutical use
JP2011509916A (ja) チアゾリジン誘導体およびその製造方法
JPWO2002046176A1 (ja) ペルオキシソーム増殖剤応答性受容体の活性化剤
JP6595475B2 (ja) S1p3アンタゴニスト
JPWO2002046161A1 (ja) 置換カルボン酸誘導体
US7585895B2 (en) Therapeutic substituted cyclopentanes
JP4488732B2 (ja) ベンズオキサゾール化合物及びこれを含有する医薬組成物
HUP0300857A2 (hu) Peroxiszóma proliferátor aktivált agonisták
CN104159892A (zh) 被取代的苯基唑衍生物
HUP0400043A2 (hu) HPPAR-alfa receptor aktiváló hatású oxazol/tiazol-származékok és ezeket tartalmazó gyógyszerkészítmények
JPWO2002044130A1 (ja) 置換カルボン酸誘導体
US7141591B2 (en) 1,2,4-oxadiazole derivatives as hPPAR alpha agonists